BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · page 9 of 15
The chart displays the first principal component for each pathway over 20 weeks, comparing NurOwn and Placebo groups.
Conference presentation · key_takeaways · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
chart 1/1 list 2/2 paragraph 1/1 source-note 1/1 title 2/2
Components 7
line bullet bullet paragraph source-note action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1